Delivery Order SPE2DB24D2205-SPE2DB25FEEHL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,990.81 to AmerisourceBergen Drug Corp for PRIORIX vials on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,514.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,868.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PRIORIX vials, with a completion date of September 16, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PRIORIX is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this delivery order part of the DLA's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials, valued at $1,009.42, with an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order issued under a competitive procurement process with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $14,845.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of June 10, 2025. This is a non-set-aside competitive award executed on June 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.10 to AmerisourceBergen Drug Corp for Priorix vials on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order was issued without a set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a $87,375.60 delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a $4,706.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with performance at the company's Conshohocken, Pennsylvania location. The contract, with an ultimate completion date of October 28, 2025, was competitively awarded without set-aside designation. This delivery order is a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $19,416.80 delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials under a firm fixed-price contract. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and does not utilize a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PRIORIX vials valued at $10,892.18 under a Firm Fixed Price contract type. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. PRIORIX is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, and this delivery order falls under AmerisourceBergen's broader pharmaceutical supply...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEHLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,047.10 to AmerisourceBergen Drug Corp for the supply of PRIORIX vials, with a completion date of July 1, 2025. The contract utilizes firm fixed-price pricing and was awarded without a set-aside designation, indicating competitive selection among qualified vendors. Performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and a major distribution hub for pharmaceutical and medical supply operations. This delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical commodities to military healthcare programs and other federal medical systems. PRIORIX, a measles-mumps-rubella vaccine, aligns with the vaccine supply requirements outlined in the broader IDC and supports the Defense Health Agency's medical readiness objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 6/30/25 |